PYC Therapeutics Limited ( (AU:PYC) ) just unveiled an announcement.
PYC Therapeutics Limited announced the quotation of 72,984,880 fully paid ordinary securities on the Australian Securities Exchange (ASX). This move is part of previously announced transactions and is expected to enhance the company’s market presence and provide additional capital for its ongoing research and development efforts.
More about PYC Therapeutics Limited
PYC Therapeutics Limited operates in the biotechnology industry, focusing on developing innovative therapies. The company specializes in creating precision medicines aimed at treating genetic disorders, leveraging its proprietary drug development platform.
YTD Price Performance: -6.11%
Average Trading Volume: 424,379
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$717.4M
Learn more about PYC stock on TipRanks’ Stock Analysis page.